drugset / Trial / NCT03927677

The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.

NCT03927677

Phase 1 Completed 24 enrolled LG Chem
SequentialOpen-labelTreatment

Summary

This is a Phase 1, open-label, fixed-sequence, 3-period, 2-way drug interaction study designed to assess the PK, PD, safety, and tolerability of LC350189 and colchicine when administered alone and in combination in healthy subjects.

Timeline

Start
2019-11-05
Primary completion
2019-11-26
Completion
2019-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Tigulixostat Small molecule 200 mg

Indications